Towards Multitargeted Ligands as Pain Therapeutics: Dual Ligands of the Cavα2δ‐1 Subunit of Voltage‐Gated Calcium Channel and the μ‐Opioid Receptor
- 17 January 2024
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 19 (10) , e202300473
Abstract
The synthesis and pharmacological activity of a new series of dual ligands combining activities towards the α2δ‐1 subunit of voltage‐gated calcium channels (Cavα2δ‐1) and the μ‐opioid receptor (MOR) as novel pain therapeutics are reported. A careful exploration of the pharmacophores related to both targets, which in principle had few common characteristics, led to the design of novel compounds exhibiting both activities. The construction of the dual ligands started from published Cavα2δ‐1 ligands, onto which MOR ligand pharmacophoric elements were added. This exercise led to new amino‐acidic substances with good affinities on both targets as well as good metabolic and physicochemical profiles and low potential for drug‐drug interactions. A representative compound, (2S,4S)‐4‐(4‐chloro‐3‐(((cis)‐4‐(dimethylamino)‐4‐phenylcyclohexyl)methyl)‐5‐fluorophenoxy)pyrrolidine‐2‐carboxylic acid, displayed promising analgesic activities in several in vivo pain models as well as a reduced side‐effect profile in relation to morphine.Keywords
This publication has 59 references indexed in Scilit:
- A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with MorphineThe Journal of Pharmacology and Experimental Therapeutics, 2013
- Combination Therapy for Neuropathic PainCNS Drugs, 2011
- Pain as a global public health priorityBMC Public Health, 2011
- Combination Drug Therapy for Chronic Pain: A Call for More Clinical StudiesThe Journal of Pain, 2011
- Causes and Consequences of Inadequate Management of Acute PainPain Medicine, 2010
- The Determination and Application of Fixed-Dose Analgesic Combinations for Treating Multimodal PainThe Journal of Pain, 2010
- Targeting Voltage-Gated Calcium Channels for Neuropathic Pain ManagementNeurotherapeutics, 2009
- Functional biology of the α2δ subunits of voltage-gated calcium channelsTrends in Pharmacological Sciences, 2007
- Expedited SAR study of high-affinity ligands to the α2δ subunit of voltage-gated calcium channels: Generation of a focused library using a solution-phase Sn2Ar coupling methodologyBioorganic & Medicinal Chemistry Letters, 2006
- Pharmacological characterisation of a rat model of incisional painBritish Journal of Pharmacology, 2004